Boston Globe - NEW YORK — An HSBC analyst upgraded Sanofi- Aventis SA Wednesday, citing the French drug maker’s full pipeline and shrugging off its failure to receive U.S. approval for the weight-loss drug Acomplia. In late June, Sanofi-Aventis withdrew its
Source: www.boston.com

Weight Loss Drug Linked to Suicide Risk
FOX News - The European Medicines Agency (EMEA) said this week a stronger warning is needed on the weightloss drug Acomplia (rimonabant) from sanofi-aventis, which has been linked to an increased suicide risk. The EMEA said it is especially important the people
Source: www.foxnews.com

Soy protein hydrolysate shows promise for weight management
Nutra Ingredients USA - The research, published in the journal Metabolism , could tap into the burgeoning weight loss and management market, estimated to already be worth $7bn ( 5.2bn) globally. It also has implications for diabetes. With 50 per cent of Europeans and 62 per
Source: www.nutraingredients-usa.com

This entry was posted on Saturday, July 21st, 2007 at 12:45 am and is filed under Best Weight Loss Information. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.